It’s nearing the end of #DepositorWeek at Addgene and we’d like to show our gratitude on the blog by highlighting some of the great posts written by Addgene depositors. Below you’ll find brief summaries of several excellent guest posts from our depositors. Interested in writing ...
All plasmids deposited at Addgene enhance scientific sharing worldwide but a select few are particularly special. Over 1000 of our 60,000+ deposited plasmids have been requested more than 100 times each, thereby achieving the coveted “blue flame” status. We’re proud to honor the ...
Gladys Kaba from the University of Health and Allied Sciences in Ghana will be receiving the third Addgene/Seeding Labs plasmid grant and plans to use the grant to order plasmids she can use as positive controls in PCR-based cervical cancer screens.
Read All of Our Editor's Choice Blog Posts Last month there was plenty of excitement at Addgene. Our new viral service has begun to pick up steam (we already have over 70 orders!), we sent Outreach Scientists to Colorado, Berlin, Atlanta, Ottawa, Norwich, and Hannover, we raised ...
Read All of Our Editor's Choice Blog Posts As I’m sitting in the San Francisco International Airport listening to the Lion King soundtrack and writing this post, it is my pleasure to announce that we once again reached new heights on the Addgene blog: we surpassed 60,000 views ...
I’ve answered hundreds of phone calls and thousands of customer service emails in my six years as a senior scientist at Addgene. Having spent that long in customer service, I've daydreamed about the ideal customer service interaction - one that gives our customers the most ...
This post was contributed by Kurt Swanson a structural biologist and protein engineer currently working at Sanofi Pharmaceuticals in Cambridge, MA. When I joined Sanofi/Genzyme nearly three years ago I decided it was time to get in shape. After three kids, I had put on typical ...
Cancer – a term familiar to almost every person regardless of profession, race, or gender. Almost no other disease receives as many billions of dollars in funding or as much attention collectively from researchers. Scientists, however, have yet to slay the beast. On a global ...
